Summary & Overview
HCPCS Level II J3302: Triamcinolone Diacetate Injection, per 5 mg
HCPCS Level II code J3302 denotes an injectable corticosteroid: triamcinolone diacetate billed per 5 mg. This code is commonly used in outpatient and ambulatory settings for anti-inflammatory indications across specialties such as rheumatology, dermatology, and physical medicine. Nationally, accurate use of J3302 matters for consistent medication billing, inventory tracking, and proper claim adjudication given variability in payer coverage policies for injectable drugs.
Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of coverage and billing considerations across these payers, typical sites of service where the code is used, common modifiers and ancillary billing elements (where available), and context on clinical indication and administration that influence coding and claims processing.
This publication provides benchmarks and policy context relevant to billing administrators, practice managers, and compliance staff, and summarizes clinical and administrative factors that affect reimbursement and utilization for J3302. Data not available in the input will be noted where applicable.
Billing Code Overview
HCPCS Level II code J3302 describes an injection of triamcinolone diacetate, billed per 5 mg unit. This code represents a corticosteroid medication administered by injection for anti-inflammatory purposes.
Service type: Injection, medication administration
Typical site of service: Outpatient clinic, physician office, or ambulatory care setting
Clinical & Coding Specifications
Clinical Context
A 54-year-old patient presents to an outpatient orthopedic or pain-management clinic with focal inflammatory musculoskeletal pain — for example, persistent lateral epicondylitis, trigger finger, or a localized subacromial bursitis — unresponsive to conservative measures (rest, NSAIDs, physical therapy). After clinical assessment and informed consent, the clinician prepares a corticosteroid injection containing triamcinolone diacetate, dosed in 5 mg increments billed with J3302 (injection, triamcinolone diacetate, per 5 mg). The procedure typically occurs in an ambulatory clinic, physician office, or outpatient surgical center.
The workflow includes: pre-procedure assessment and relevant medication reconciliation; aseptic preparation of the injection site; optional local anesthetic administration; anatomical localization (palpation or ultrasound guidance when indicated); administration of the triamcinolone diacetate injection into the targeted tendon sheath, bursa, or joint; post-procedure observation for immediate reactions; and documentation of medication, dose (number of J3302 units), injection site, laterality, and patient instructions. Typical sites of service are the physician office, outpatient clinic, or ambulatory surgical center.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 |